Advanced search
Publication Cover
Renal Failure Volume 37, 2015 - Issue 2
Submit an article Journal homepage
992
Views
3
CrossRef citations to date
0
Altmetric
Laboratory Study

Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats

Xiao TanDepartment of Nephrology, Shanghai Institute of Kidney and Dialysis, Shanghai Key Laboratory of Kidney and Blood Purification, Zhongshan Hospital, Fudan University, Shanghai, China,
,
Jianqiang HeJiangsu University Affiliated Hospital, Zhenjiang City, Jiangsu Province, China,
,
Xuesen CaoDialysis Center, Zhongshan Hospital Fudan University, Shanghai, China, and
,
Jianzhou ZouDialysis Center, Zhongshan Hospital Fudan University, Shanghai, China, and
,
Hong LiuDepartment of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China
&
Xiaoqiang DingDepartment of Nephrology, Shanghai Institute of Kidney and Dialysis, Shanghai Key Laboratory of Kidney and Blood Purification, Zhongshan Hospital, Fudan University, Shanghai, China, Correspondence[email protected]
Pages 337-342 | Received 14 Jul 2014, Accepted 27 Sep 2014, Published online: 26 Nov 2014

References

  • Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  • Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: A population study from Beijing. Am J Kidney Dis. 2008;51:373–384
  • Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives—A position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–259
  • Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284
  • Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J. A bench to bedside view of uremic toxins. J Am Soc Nephrol. 2008;19:863–870
  • Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–1943
  • Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G. An update on uremic toxins. Int Urol Nephrol. 2013;45:139–150
  • Schulman G, Vanholder R, Niwa T. AST-120 for the management of progression of chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:49–56
  • Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis. 2006;47:565–577
  • Marier JF, Lee J, Kambhampati SR, et al. Effect of repeated oral administrations of the oral adsorbent AST-120 on serum creatinine and other markers of renal function. A randomized controlled study in patients with chronic kidney disease. Am J Nephrol. 2006;26:136–141
  • Kobayashi N, Maeda A, Horikoshi S, Shirato I, Tomino Y, Ise M. Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats. Nephron. 2002;91:480–485
  • Konishi K, Nakano S, Tsuda S, Nakagawa A, Kigoshi T, Koya D. AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects. Diabetes Res Clin Pract. 2008;81:310–315
  • Bellizzi V. Low-protein diet or nutritional therapy in chronic kidney disease? Blood Purif. 2013;36:41–46
  • Hostetter TH, Meyer TW, Rennke HG, Brenner BM. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int. 1986;30:509–517
  • Imai E, Takenaka M, Isaka Y, et al. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet. Clin Exp Nephrol. 2003;7:113–119
  • Sanaka T, Fujimoto K, Niwayama J, et al. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Am J Kidney Dis. 2003;41:S35–S37
  • Niwa T, Emoto Y, Maeda K, Uehara Y, Yamada N, Shibata M. Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of hemodialysis patients. Nephrol Dial Transplant. 1991;6:105–109
  • Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med. 1994;124:96–104
  • Kanai F, Takahama T, Yamazaki Z, Idezuki Y, Koide K. Effects of oral adsorbent on experimental uremic rats. Nihon Jinzo Gakkai Shi. 1986;28:1249–1259

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.